content: <PAGE>
   
                        SECURITIES AND EXCHANGE COMMISSION
  
                              WASHINGTON, D.C. 20549
  
  
                                     FORM 8-K
  
                                  CURRENT REPORT
                          PURSUANT TO SECTION 13 OR 15(d)
                      OF THE SECURITIES EXCHANGE ACT OF 1934
  
  
       DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):  FEBRUARY 27, 1998
  
  
  
                            BORLAND INTERNATIONAL, INC.
              (Exact name of registrant as specified in its charter)
  
  
     DELAWARE                      33-80946                        94-2895440
  (State or other          (Commission File Number)            (I.R.S. Employer
  jurisdiction of                                             Identification No.)
  incorporation or 
  organization)     
  
  
             100 BORLAND WAY
         SCOTTS VALLEY, CALIFORNIA                               95066-3249
  (Address of principal executive offices)                       (Zip Code)
  
  
        Registrant's telephone number, including area code:  (408) 431-1000
  
                                  Not applicable.
                    -------------------------------------------
           (Former name or former address, if changed since last report)
  <PAGE>
   
  ITEM 2.  ACQUISITION OR DISPOSITION OF ASSETS
  
       On February 27, 1998, Borland International, Inc. (the "Company") completed
  its acquisition (the "Merger") of Visigenic Software, Inc. ("Visigenic").   To
  effect the Merger, a wholly-owned subsidiary of the Company was merged with and
  into Visigenic, with Visigenic the surviving corporation in the Merger. The
  Merger will be recorded as a pooling of interests for accounting purposes.
  
       In the Merger, each outstanding share of common stock of Visigenic
  ("Visigenic Common Stock") was converted into the right to receive 0.81988 of a
  share of the common stock of the Company ("Company Common Stock").  All
  outstanding options to acquire Visigenic Common Stock were assumed by the
  Company and will be exercisable for shares of Company Common Stock based upon
  the same conversion ratio.  The Company will issue approximately 12,118,060
  shares of Company Common Stock in exchange for all outstanding shares of
  Visigenic Common Stock.  In addition, the Company has reserved 2,527,287
  additional shares of Company Common Stock for issuance upon the exercise of
  options to purchase Visigenic Common Stock assumed by the Company in the Merger.
  
  ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS.
  
          (a)     FINANCIAL STATEMENTS OF BUSINESS ACQUIRED. The financial
                  statements required pursuant to Rule 3-05 of Regulation S-X were
                  previously reported in the Company's Registration Statement on
                  Form S-4, as filed with the Securities and Exchange Commission
                  on January 27, 1998, and pursuant to General Instruction B.3 of
                  Form 8-K are not additionally reported herein.
  
          (b)     PRO FORMA FINANCIAL INFORMATION. The financial information
                  required pursuant to Article 11 of Regulation S-X was previously
                  reported in the Company's Registration Statement or Form S-4, as
                  filed with the Securities and Exchange Commission on January 27,
                  1998, and pursuant to General Instruction B.3 of Form 8-K is not
                  additionally reported herein.
  
          (c)     EXHIBITS.
  
  <TABLE>
  <CAPTION>
  Exhibit No.     Description
  -----------     -----------
   
  <S>                 <C>
   2.1*           Agreement and Plan of Merger, dated as of November 17, 1997,
                  among Borland, Vixen Acquisition Corporation, a Delaware
                  corporation and wholly-owned subsidiary of Borland, and
                  Visigenic Software, Inc.
                  
  99.1            Press release announcing completion of the Merger.
  </TABLE>
  
  __________________________
  *  Filed as Exhibit 2.1 to the Company's Registration Statement on Form S-4
  filed with the Securities and Exchange Commission on January 27, 1998 and
  incorporated herein by reference.
  
                                         2
  <PAGE>
   
                                    SIGNATURES
  
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
  
                                      Borland International,  Inc.
  
  
  
  March 10, 1998                      By:  /s/ Kathleen M. Fisher
                                           ----------------------
                                            Kathleen M. Fisher,
                                            Vice President and Chief Financial
                                            Officer
  
  
  
  
  
  
                                         3
  <PAGE>
   
                                   EXHIBIT INDEX
  
  
  
  <TABLE>
  <CAPTION>
  Exhibit No.     Description
  -----------     -----------
  <C>             <S>
   2.1*           Agreement and Plan of Merger, dated as of November 17, 1997,
                  among Borland, Vixen Acquisition Corporation, a Delaware
                  corporation and wholly-owned subsidiary of Borland, and Visigenic
                  Software, Inc.
            
  99.1            Press release announcing completion of the Merger.
  </TABLE>
  
  
  _______________
  *  Filed as Exhibit 2.1 to the Company's Registration Statement on Form S-4
  filed with the Securities and Exchange Commission on January 27, 1998 and
  incorporated herein by reference.
metadata_documents: [{"type": "8-K", "sequence": "1", "description": "FORM 8-K", "secsgml_size_bytes": 5506}]
metadata_filer: {"company-data": {"conformed-name": "BORLAND INTERNATIONAL INC /DE/", "cik": "0000853273", "assigned-sic": "7372", "irs-number": "942895440", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-10824", "film-number": "98564317"}, "business-address": {"street1": "100 BORLAND WAY", "city": "SCOTTS VALLEY", "state": "CA", "zip": "95066-3249", "phone": "4084311000"}, "mail-address": {"street1": "100 BORLAND WAY", "city": "SCOTTS VALLEY", "state": "CA", "zip": "95066"}, "former-company": {"former-conformed-name": "BORLAND INTERNATIONAL DELAWARE INC", "date-changed": "19891011"}}
text: SECURITIES AND EXCHANGE COMMISSION
  
                              WASHINGTON, D.C. 20549
  
                                     FORM 8-K
  
                                  CURRENT REPORT
                          PURSUANT TO SECTION 13 OR 15(d)
                      OF THE SECURITIES EXCHANGE ACT OF 1934
  
       DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):  FEBRUARY 27, 1998
  
                            BORLAND INTERNATIONAL, INC.
              (Exact name of registrant as specified in its charter)
  
     DELAWARE                      33-80946                        94-2895440
  (State or other          (Commission File Number)            (I.R.S. Employer
  jurisdiction of                                             Identification No.)
  incorporation or 
  organization)     
  
             100 BORLAND WAY
         SCOTTS VALLEY, CALIFORNIA                               95066-3249
  (Address of principal executive offices)                       (Zip Code)
  
        Registrant's telephone number, including area code:  (408) 431-1000
  
                                  Not applicable.
                    -------------------------------------------
           (Former name or former address, if changed since last report)
  ITEM 2.  ACQUISITION OR DISPOSITION OF ASSETS
  
       On February 27, 1998, Borland International, Inc. (the "Company") completed
  its acquisition (the "Merger") of Visigenic Software, Inc. ("Visigenic").   To
  effect the Merger, a wholly-owned subsidiary of the Company was merged with and
  into Visigenic, with Visigenic the surviving corporation in the Merger. The
  Merger will be recorded as a pooling of interests for accounting purposes.
  
       In the Merger, each outstanding share of common stock of Visigenic
  ("Visigenic Common Stock") was converted into the right to receive 0.81988 of a
  share of the common stock of the Company ("Company Common Stock").  All
  outstanding options to acquire Visigenic Common Stock were assumed by the
  Company and will be exercisable for shares of Company Common Stock based upon
  the same conversion ratio.  The Company will issue approximately 12,118,060
  shares of Company Common Stock in exchange for all outstanding shares of
  Visigenic Common Stock.  In addition, the Company has reserved 2,527,287
  additional shares of Company Common Stock for issuance upon the exercise of
  options to purchase Visigenic Common Stock assumed by the Company in the Merger.
  
  ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS.
  
          (a)     FINANCIAL STATEMENTS OF BUSINESS ACQUIRED. The financial
                  statements required pursuant to Rule 3-05 of Regulation S-X were
                  previously reported in the Company's Registration Statement on
                  Form S-4, as filed with the Securities and Exchange Commission
                  on January 27, 1998, and pursuant to General Instruction B.3 of
                  Form 8-K are not additionally reported herein.
  
          (b)     PRO FORMA FINANCIAL INFORMATION. The financial information
                  required pursuant to Article 11 of Regulation S-X was previously
                  reported in the Company's Registration Statement or Form S-4, as
                  filed with the Securities and Exchange Commission on January 27,
                  1998, and pursuant to General Instruction B.3 of Form 8-K is not
                  additionally reported herein.
  
          (c)     EXHIBITS.
  Exhibit No.     Description
  -----------     -----------
  2.1*           Agreement and Plan of Merger, dated as of November 17, 1997,
                  among Borland, Vixen Acquisition Corporation, a Delaware
                  corporation and wholly-owned subsidiary of Borland, and
                  Visigenic Software, Inc.
                  
  99.1            Press release announcing completion of the Merger.
  __________________________
  *  Filed as Exhibit 2.1 to the Company's Registration Statement on Form S-4
  filed with the Securities and Exchange Commission on January 27, 1998 and
  incorporated herein by reference.
  
                                         2
  SIGNATURES
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
                                      Borland International,  Inc.
  
  March 10, 1998                      By:  /s/ Kathleen M. Fisher
                                           ----------------------
                                            Kathleen M. Fisher,
                                            Vice President and Chief Financial
                                            Officer
  
                                         3
  EXHIBIT INDEX
  Exhibit No.     Description
  -----------     -----------
  2.1*           Agreement and Plan of Merger, dated as of November 17, 1997,
                  among Borland, Vixen Acquisition Corporation, a Delaware
                  corporation and wholly-owned subsidiary of Borland, and Visigenic
                  Software, Inc.
            
  99.1            Press release announcing completion of the Merger.
  _______________
  *  Filed as Exhibit 2.1 to the Company's Registration Statement on Form S-4
  filed with the Securities and Exchange Commission on January 27, 1998 and
  incorporated herein by reference.